Potassium%252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCL) is an electrolyte supplement used to treat or prevent hypokalemia. It is available in oral and intravenous formulations. ## Primary Indications * Treatment and prevention of hypokalemia. * Potassium replacement in patients receiving diuretics or corticosteroids, or experiencing significant GI losses. ## Adult Dosing Dosing is highly individualized based on serum potassium levels, severity of deficit, and clinical context. * **Oral Maintenance:** 20-40 mEq per day in 1-2 divided doses. * **Oral Treatment of Hypokalemia:** 40-100 mEq per day in 2-4 divided doses. * **Maximum oral dose:** Generally not to exceed 20 mEq per dose or 100-120 mEq per day without close monitoring. Some sources suggest a maximum of 200 mEq/day in severe, refractory cases under strict supervision. * **Intravenous (IV) Treatment of Hypokalemia:** Dosing depends on severity and serum potassium. * **Mild to moderate hypokalemia (serum K 3.0-3.4 mEq/L):** Typically 10-20 mEq IV added to 1 L of IV fluid, infused over 2-4 hours. * **Severe hypokalemia (serum K < 2.5 mEq/L) or symptomatic:** May require more aggressive IV replacement, up to 40 mEq/hour. * **Maximum IV infusion rate:** Generally recommended at $\le$ 10-20 mEq/hour. Infusion rates > 20 mEq/hour, especially in peripheral veins, carry a high risk of phlebitis and cardiac arrhythmias and should only be administered via central line with continuous cardiac monitoring. * **Maximum IV dose:** Doses of 400 mEq in 24 hours have been used in severe, life-threatening hypokalemia under intensive care monitoring. * **Standard IV Fluids:** IV KCL is typically added to normal saline (NS) or dextrose 5% in water (D5W). However, caution is advised when adding potassium to D5W in patients with severe hypokalemia, as insulin release stimulated by glucose can further lower serum potassium. ## Pediatric Dosing Dosing is based on age, weight, and serum potassium levels. Local protocols are often used. * **Oral Maintenance:** 1-2 mEq/kg/day, not to exceed adult maximums. * **Oral Treatment of Hypokalemia:** Up to 3-5 mEq/kg/day, divided into 2-4 doses. * **Maximum oral dose:** Generally $\le$ 40 mEq/day in infants and young children, up to 100 mEq/day in older children, without close monitoring. * **Intravenous (IV) Treatment of Hypokalemia:** * **General range:** 0.5-1 mEq/kg/dose up to a maximum of 20 mEq per dose. * **Maximum infusion rate:** $\le$ 10 mEq/hour. * **Maximum concentration:** Typically 40 mEq/L in peripheral IV fluids. Higher concentrations (up to 80 mEq/L) may be used in central lines with continuous cardiac monitoring, but this requires strict adherence to local protocols. * **Daily maximum:** Dosing up to 200 mEq/m²/day has been described in severe cases. ## Dose Adjustments * **Renal Impairment:** Potassium chloride should be used with extreme caution or avoided in patients with significant renal impairment due to the risk of hyperkalemia. * **Adrenal Insufficiency:** Use with caution. ## Contraindications * Hyperkalemia. * Conditions that may predispose to hyperkalemia such as: * Untreated Addison's disease. * Certain types of renal disease. * Anuria. * Oliguria. * Extensive tissue breakdown (e.g., severe burns, crush injuries). * Specific formulations may have additional contraindications (e.g., delayed-release preparations in patients with GI motility disorders). ## Adverse Effects * **Gastrointestinal:** Nausea, vomiting, abdominal pain, diarrhea, flatulence, dysphagia. Oral formulations can cause gastrointestinal irritation, ulceration, bleeding, and perforation, especially if not taken with sufficient fluid or if enteric-coated formulations are used in patients with delayed gastric emptying. * **Cardiovascular:** Hyperkalemia (can lead to ECG changes, arrhythmias, cardiac arrest). * **Neuromuscular:** Weakness, paresthesias, paralysis. * **Other:** Phlebitis (IV administration), vein irritation. ## Key Drug Interactions * **ACE Inhibitors, ARBs, Aldosterone Antagonists (e.g., spironolactone), Potassium-Sparing Diuretics (e.g., amiloride, triamterene):** Increased risk of hyperkalemia. Monitor potassium closely. * **NSAIDs:** May decrease potassium excretion and increase the risk of hyperkalemia. * **Digoxin:** Hyperkalemia can increase the toxicity of digoxin; hypokalemia can increase the sensitivity to digoxin. * **Neuromuscular Blocking Agents:** Potassium can affect neuromuscular transmission and may potentiate or antagonize the effects of these agents. ## Monitoring * **Serum Potassium Levels:** Essential for guiding dosing and assessing response. Frequency depends on severity, route of administration, and patient condition. * **Renal Function (BUN, Creatinine):** To assess ability to excrete potassium. * **ECG:** Especially during rapid IV infusions or in patients with pre-existing cardiac conditions or severe hypokalemia, to monitor for signs of hyperkalemia. * **Signs and Symptoms of Hypokalemia and Hyperkalemia:** Muscle weakness, fatigue, palpitations, paresthesias, arrhythmias. ## Clinical Pearls * Oral potassium supplements should always be taken with sufficient fluid (e.g., a full glass of water) to minimize gastrointestinal irritation. * Enteric-coated or sustained-release potassium chloride tablets carry a higher risk of gastrointestinal ulceration and should be used with caution, particularly in patients with delayed gastric emptying or those taking medications that slow GI motility. Liquid or powder formulations may be preferred in such patients. * IV potassium is a vesicant and should be infused slowly and diluted appropriately. Central venous access is preferred for higher concentrations and faster infusion rates. * Never administer potassium chloride as an IV bolus injection due to the high risk of cardiac arrest. * Consider the underlying cause of hypokalemia and address it if possible. --- *This information is intended for healthcare professionals. Always consult the most current prescribing information and relevant clinical guidelines for complete details, including specific contraindications, warnings, and precautions, as product formulations and recommendations can change.*